1. Home
  2. LYRA vs LOBO Comparison

LYRA vs LOBO Comparison

Compare LYRA & LOBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LYRA
  • LOBO
  • Stock Information
  • Founded
  • LYRA 2005
  • LOBO 2014
  • Country
  • LYRA United States
  • LOBO China
  • Employees
  • LYRA N/A
  • LOBO N/A
  • Industry
  • LYRA Medical/Dental Instruments
  • LOBO
  • Sector
  • LYRA Health Care
  • LOBO
  • Exchange
  • LYRA Nasdaq
  • LOBO NYSE
  • Market Cap
  • LYRA 18.0M
  • LOBO 19.9M
  • IPO Year
  • LYRA 2020
  • LOBO 2024
  • Fundamental
  • Price
  • LYRA $0.17
  • LOBO $2.15
  • Analyst Decision
  • LYRA Buy
  • LOBO
  • Analyst Count
  • LYRA 5
  • LOBO 0
  • Target Price
  • LYRA $4.50
  • LOBO N/A
  • AVG Volume (30 Days)
  • LYRA 2.2M
  • LOBO 27.1K
  • Earning Date
  • LYRA 11-12-2024
  • LOBO 11-25-2024
  • Dividend Yield
  • LYRA N/A
  • LOBO N/A
  • EPS Growth
  • LYRA N/A
  • LOBO N/A
  • EPS
  • LYRA N/A
  • LOBO 0.00
  • Revenue
  • LYRA $1,471,000.00
  • LOBO $19,469,766.00
  • Revenue This Year
  • LYRA $13.99
  • LOBO $72.16
  • Revenue Next Year
  • LYRA N/A
  • LOBO $41.04
  • P/E Ratio
  • LYRA N/A
  • LOBO $1,805.80
  • Revenue Growth
  • LYRA 3.37
  • LOBO N/A
  • 52 Week Low
  • LYRA $0.17
  • LOBO $1.35
  • 52 Week High
  • LYRA $6.79
  • LOBO $4.70
  • Technical
  • Relative Strength Index (RSI)
  • LYRA 30.70
  • LOBO N/A
  • Support Level
  • LYRA $0.26
  • LOBO N/A
  • Resistance Level
  • LYRA $0.28
  • LOBO N/A
  • Average True Range (ATR)
  • LYRA 0.02
  • LOBO 0.00
  • MACD
  • LYRA -0.01
  • LOBO 0.00
  • Stochastic Oscillator
  • LYRA 1.69
  • LOBO 0.00

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioresorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver up to six months of continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

About LOBO LOBO EV TECHNOLOGIES LTD

Lobo EV Technologies Ltd is an electric vehicle manufacturer and seller company. It designs, develops, manufactures, and sells e-bicycles, e-mopeds, e-tricycles, and electric off-highway four-wheeled shuttles such as golf carts and mobility scooters for the elderly and disabled persons, also provides automobile information and entertainment software development and design services to customers. The company operates in two operating segments: Electric vehicles and accessories sales which generates key revenue, and software royalties and development and design services. It generates all of its revenue within the People's Republic of China.

Share on Social Networks: